Literature DB >> 32286926

Is glucose-6-phosphate dehydrogenase enzyme deficiency a factor in Coronavirus-19 (COVID-19) infections and deaths?

Duygu Aydemir1,2, Nuriye Nuray Ulusu1,2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32286926      PMCID： PMC7241485          DOI： 10.1080/20477724.2020.1751388

Source DB:  PubMed          Journal:  Pathog Glob Health        ISSN： 2047-7724            Impact factor:   2.894


× No keyword cloud information.
  3 in total

1.  Glucose-6-phosphate dehydrogenase deficiency and Alzheimer's disease: Partners in crime? The hypothesis.

Authors:  N Nuray Ulusu
Journal:  Med Hypotheses       Date:  2015-05-11       Impact factor: 1.538

2.  In vitro interaction of glutathione S-transferase-pi enzyme with glutathione-coated silver sulfide quantum dots: A novel method for biodetection of glutathione S-transferase enzyme.

Authors:  Duygu Aydemir; Mahshid Hashemkhani; Havva Yagci Acar; Nuriye Nuray Ulusu
Journal:  Chem Biol Drug Des       Date:  2019-09-07       Impact factor: 2.817

3.  Glucose-6-phosphate dehydrogenase deficiency enhances human coronavirus 229E infection.

Authors:  Yi-Hsuan Wu; Ching-Ping Tseng; Mei-Ling Cheng; Hung-Yao Ho; Shin-Ru Shih; Daniel Tsun-Yee Chiu
Journal:  J Infect Dis       Date:  2008-03-15       Impact factor: 5.226
  3 in total
  11 in total

1.  Overview of the Haematological Effects of COVID-19 Infection.

Authors:  T M Wiggill; E S Mayne; J L Vaughan; S Louw
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

2.  The Possible Role of Glucose-6-Phosphate Dehydrogenase in the SARS-CoV-2 Infection.

Authors:  Israel Pérez-Torres; María Elena Soto; Verónica Guarner-Lans; Linaloe Manzano-Pech; Elizabeth Soria-Castro
Journal:  Cells       Date:  2022-06-21       Impact factor: 7.666

Review 3.  Current investigations on clinical pharmacology and therapeutics of Glucose-6-phosphate dehydrogenase deficiency.

Authors:  Kaitlyn Ryan; Babu L Tekwani
Journal:  Pharmacol Ther       Date:  2020-12-14       Impact factor: 13.400

4.  Human Leukocyte Antigen Complex and Other Immunogenetic and Clinical Factors Influence Susceptibility or Protection to SARS-CoV-2 Infection and Severity of the Disease Course. The Sardinian Experience.

Authors:  Roberto Littera; Marcello Campagna; Silvia Deidda; Goffredo Angioni; Selene Cipri; Maurizio Melis; Davide Firinu; Simonetta Santus; Alberto Lai; Rita Porcella; Sara Lai; Stefania Rassu; Rosetta Scioscia; Federico Meloni; Daniele Schirru; William Cordeddu; Marta Anna Kowalik; Maria Serra; Paola Ragatzu; Mauro Giovanni Carta; Stefano Del Giacco; Angelo Restivo; Simona Deidda; Sandro Orrù; Antonella Palimodde; Roberto Perra; Germano Orrù; Maria Conti; Cinzia Balestrieri; Giancarlo Serra; Simona Onali; Francesco Marongiu; Andrea Perra; Luchino Chessa
Journal:  Front Immunol       Date:  2020-12-04       Impact factor: 7.561

5.  Methemoglobinemia in Patient with G6PD Deficiency and SARS-CoV-2 Infection.

Authors:  Kieran Palmer; Jonathan Dick; Winifred French; Lajos Floro; Martin Ford
Journal:  Emerg Infect Dis       Date:  2020-06-24       Impact factor: 6.883

6.  The potential link between inherited G6PD deficiency, oxidative stress, and vitamin D deficiency and the racial inequities in mortality associated with COVID-19.

Authors:  Sushil K Jain; Rajesh Parsanathan; Steve N Levine; Joseph A Bocchini; Michael F Holick; John A Vanchiere
Journal:  Free Radic Biol Med       Date:  2020-10-07       Impact factor: 7.376

7.  G6PD deficiency, redox homeostasis, and viral infections: implications for SARS-CoV-2 (COVID-19).

Authors:  Hung-Chi Yang; Tian-Hsiang Ma; Wen-Ye Tjong; Arnold Stern; Daniel Tsun-Yee Chiu
Journal:  Free Radic Res       Date:  2021-01-06

8.  Neutrophil to lymphocyte ratio, lymphocyte to monocyte ratio and platelet to lymphocyte ratio to predict the severity of COVID-19.

Authors:  Murat Seyit; Esin Avci; Rukiye Nar; Hande Senol; Atakan Yilmaz; Mert Ozen; Alten Oskay; Hulya Aybek
Journal:  Am J Emerg Med       Date:  2020-12-06       Impact factor: 2.469

9.  Correspondence: Importance of the validated serum biochemistry and hemogram parameters for rapid diagnosis and to prevent false negative results during COVID-19 pandemic.

Authors:  Duygu Aydemir; Nuriye Nuray Ulusu
Journal:  Biotechnol Appl Biochem       Date:  2020-05-21       Impact factor: 2.724

10.  [Influence of COVID-19 on the occurrence and treatment of hemolytic diseases].

Authors:  Z Wang; Y P Zhao
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  2020-10-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.